论文部分内容阅读
来自Johns Hopkins Kimmel癌症中心的临床研究支持通过乳腺导管系统直接对乳腺癌输送抗癌药的想法。“这种给药途径很有希望,它使抗癌药物被高效率地直接导入到乳腺癌组织,而不需要全身给药。”Saraswati Sukumar研究员说:“我们已经开始Ⅰ期临床试验,观察它的可行性和安全性。”
Clinical studies from the Johns Hopkins Kimmel Cancer Center support the idea of delivering anticancer drugs directly to breast cancer via the ductal system of the breast. “This route of administration is hopeful because it allows anticancer drugs to be efficiently and directly introduced into breast cancer tissue without the need for systemic administration.” Researchers at Saraswati Sukumar said: “We have started a Phase I clinical trial to see if it Feasibility and safety. ”